ScreenerHero

BIOV BioVaxys Technology Corp.

CNQ · CA · Healthcare · Biotechnology · biovaxys.com
0.0700CAD0.00%Mkt Cap: 2.07M $P/E: —

BioVaxys Technology Corp., a clinical-stage biotechnology company, engages in developing viral and oncology vaccine platforms and immuno-diagnostics. The company offers DPX immune educating technology platform and HapTen…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$128.08BUSDP/E 29.4
MRNA
Moderna, Inc.
$78.44BUSD
REGN
Regeneron Pharmaceuticals, Inc.
$76.40BUSDP/E 18.4
ARGX
argenx SE
$57.03BUSDP/E 37.3
ARGX
argenx SE
$58.08BUSDP/E 35.4
UCB
UCB SA
$42.24BUSDP/E 18.0
RVMD
Revolution Medicines, Inc.
$43.05BUSD
ONC
BeOne Medicines AG
$41.41BUSDP/E 65.1
RPRX
Royalty Pharma plc
$32.80BUSDP/E 30.2
ALNY
Alnylam Pharmaceuticals, Inc.
$30.03BUSDP/E 37.8
ROIV
Roivant Sciences Ltd.
$25.10BUSD
BNTX
BioNTech SE
$23.93BUSD
INCY
Incyte Corporation
$22.99BUSDP/E 14.5
GMAB
Genmab A/S
$22.27BUSDP/E 30.7
GMAB
Genmab A/S
$22.54BUSDP/E 28.9
INSM
Insmed Incorporated
$22.22BUSD
ASND
Ascendis Pharma A/S
$15.03BUSDP/E 17.5
JAZZ
Jazz Pharmaceuticals plc
$15.01BUSDP/E 15.8
EXEL
Exelixis, Inc.
$14.48BUSDP/E 18.4
SMMT
Summit Therapeutics Inc.
$14.32BUSD

Key Statistics

Company
Market Cap2.07M USD
Enterprise Value1.58M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-2.88M USD
Revenue/Share—
Last Price0.0700 CAD
Fiscal Year EndOct 2024
MR QuarterJul 2025
Employees—
CountryCA
SectorHealthcare
IndustryBiotechnology
ISINCA09076M1014
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B-0.56
EPS (TTM)-0.21
EPS (Forward)—
52W Range
0.030011% of range0.4000
52W High0.4000 CAD
52W Low0.0300 CAD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE205.97%
ROA-304.04%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-1.36M USD
CapEx (TTM)769.31K USD
FCF Margin—
FCF Yield-36.14%
Net Debt94.41K USD
Net Debt/EBITDA—
Balance Sheet
Debt/Equity-0.04
Current Ratio0.28
Quick Ratio0.10
Book Value/Sh-0.13 CAD
Cash/Share0.00 CAD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 CAD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Splits
Last Split1:10
Split DateSep 11, 2025
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.40.65M
Float26.14M
Insiders8.23%
Institutions0.00%
Short Interest
Short Ratio0.1d
Short % Out.0.00%
Shares Short1.56K
Short (prev mo.)1.56K
Technical
SMA 500.0700 (+0.0%)
SMA 2000.0988 (-29.2%)
Beta1.60
S&P 52W Chg16.45%
Avg Vol (30d)0
Avg Vol (10d)0
Technical Indicators
RSI (14)54.0
MACD0.0000
MACD Signal0.0000
MACD Hist.-0.0000
BB Upper0.0700 CAD
BB Middle0.0700 CAD
BB Lower0.0700 CAD
BB Width0.00%
ATR (14)0.0000 CAD
Vol Ratio (20d)—